Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 study evaluating abatacept for diffuse systemic sclerosis (scleroderma); results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Systemic Sclerosis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Stanford University | Conditions: Scleroderma, Diffuse, Scleroderma, Systemic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-04-24